Login / Signup

[Hematopoietic cell transplantation for monogenic inflammatory bowel disease].

Hirokazu KaneganeDan TomomasaKay Tanita
Published in: [Rinsho ketsueki] The Japanese journal of clinical hematology (2023)
The pathogenesis of inflammatory bowel disease (IBD) may include immune dysregulation. About 20% of inborn errors of immunity (IEIs) are related to IBD, and more than 60 IEIs are known to present IBD. Monogenic IBDs include those that are refractory to traditional treatment and can be cured by allogeneic hematopoietic cell transplantation (HCT), making early diagnosis and treatment essential. In this report, we present a series of monogenic IBDs that are relatively frequently found in Japan, such as interleukin (IL)-10/IL-10 receptor deficiency, chronic granulomatous disease, XIAP deficiency, immunodysregulation, polyendocrinopathy, enteropathy, and X-linked (IPEX) syndrome, NEMO deficiency, and A20 haploinsufficiency and will describe the features of each IEI and the indications for HCT.
Keyphrases
  • ulcerative colitis
  • replacement therapy
  • stem cell transplantation
  • bone marrow
  • case report
  • rheumatoid arthritis
  • emergency department
  • binding protein
  • combination therapy
  • hematopoietic stem cell